Gainesville Eye Associates
Gainesville, Georgia, 30501, United States
NCT Number: NCT02763124
To assess the effectiveness of the Verion-LenSx guided arcuate incision technique to reduce astigmatism in a pseudophakic population.
Looking for future studies?
Notify Me40 year and older
All sexes
Interventional
Not applicable
Gainesville, Georgia, 30501, United States
The purpose of this study is to evaluate the effectiveness of corneal arcuate incisions when they are performed with a femtosecond laser system on subjects who have had previous cataract surgery. The procedure to be used would not be different from that employed during cataract surgery, except that the only corneal incisions made would be the partial-depth arcuate incisions at the laser.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
The Verion-LenSx femtosecond laser system will be used to create one or two partial-depth corneal arcuate incisions
Time frame: 60 days (+/- 10 days) after laser treatment
Uncorrected monocular distance visual acuity, measured on a logMAR scale, (logarithm of the Minimum Angle of Resolution) which is a measure of visual acuity in which the smaller values indicate better visual acuity.
Time frame: 60 days (+/- 10 days) after laser treatment
Vector change in the astigmatism measured on the cornea, in diopters
Time frame: 60 days (+/- 10 days) after laser treatment
The vector change in refractive cylinder in diopters
Time frame: 60 days (+/- 10 days) after laser treatment
Percentage of subjects that do not rely on spectacles for distance vision
Gainesville Eye Associates
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06775509
Astigmatism, Eye Diseases
Tarragona, Spain
View Trial DetailsNCT06784063
Astigmatism, Cataract
Bloomfield Hills, Michigan, United States
View Trial DetailsNCT06749496
Astigmatism, Eye Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT06967129
Astigmatism, Eye Diseases
Mission Viejo, California, United States
View Trial Details